TheraVida
Phase 2TheraVida is dedicated to the development and commercialization of new therapies that improve the lives of patients, with fewer side effects, improved safety and efficacy, and better compliance
Founded
2010
Focus
Small Molecules
About
TheraVida is dedicated to the development and commercialization of new therapies that improve the lives of patients, with fewer side effects, improved safety and efficacy, and better compliance
Funding History
2Total raised: $12.5M
Series A$10MUndisclosedMar 15, 2014
Seed$2.5MUndisclosedJun 15, 2012
Company Info
TypePrivate
Founded2010
LocationSan Diego, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile